Skip to content

Feasibility and precision of optical coherence tomography guided and robotic-assisted PCI

Feasibility and precision of optical coherence tomography guided and robotic-assisted PCI - Robo-OCT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00024995
Enrollment
20
Registered
2023-01-23
Start date
2022-01-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20

Interventions

Group 1: Treatment algorithm (1. OCT MLD, 2. R-PCI, 3. OCT MAX)

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. = 18 years 2. Patients undergoing planned stent implantation during a clinically indicated PCI procedure 3. All target lesions must have a visually estimated or quantitatively assessed %DS of either =70%, or =50% plus one or more of the following: an abnormal functional test (e.g. fractional flow reserve, stress test) signifying ischemia in the distribution of the target lesion(s) or biomarker positive ACS with plaque disruption or thrombus. 4. Single or multi-vessel CAD 5. Informed consent

Exclusion criteria

Exclusion criteria: 1. STE-ACS within the last 7 days 2. Unstable NSTE-ACS patients 3. Previous coronary artery bypass graft (CABG) 4. Chronic total occlusion (CTO) 5. Cardiogenic shock (sustained (>10 min) systolic blood pressure < 90 mmHg) 6. Persistent ventricular arrhythmia

Design outcomes

Primary

MeasureTime frame
Primary endpoint 1.Success rate of OCT guided R-PCI (%) 2.Precision of R-PCI as determined by deviation from optimal stent landing zone (distal or proximal) (mm)

Secondary

MeasureTime frame
1. Minimal stent area (MSA) 2. Stent expansion o Acceptable stent expansion: MSA of the proximal segment is =90% of the proximal reference lumen area and the MSA of the distal segment is =90% of the distal reference lumen area o Unacceptable stent expansion: MSA of the proximal segment is <90% of the proximal reference lumen area, and/or the MSA of the distal segment is <90% of the distal reference lumen area. o Post-PCI stent expansion (%): MSA divided by the average of proximal and distal reference lumen areas x 100 3. Untreated reference segment disease o Defined as focal disease with untreated Mean Lumen Area (MLA) <4.5 mm2 within 5 mm from the proximal and/or distal stent edges 4. Edge dissections o A) Major (%): =60 degrees of the circumference of the vessel at site of dissection and/or =3 mm in length o B) Minor (%): any visible edge dissection <60 degrees of the circumference of the vessel and < 3 mm in length 5. Stent Malapposition o Frequency (%) of incompletely apposed stent struts (defined as stent struts clearly separated from the vessel wall (lumen border/plaque surface) without any tissue behind the struts with a distance from the adjacent intima of =0.2 mm and not associated with any side branch) 6. Safety – MACE (major adverse cardiovascular events)

Countries

Germany

Contacts

Public ContactConstantin von zur Mühlen

Universitätsklinikum Freiburg

constantin.vonzurmuehlen@universitaets-herzzentrum.de0761/270-34415

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026